|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-1.95% | -8.87% |
| 23-11-10 | Alvotech, Stada Get EU Panel Backing for Stelara Biosimilar | MT |
| 23-07-25 | Xbrane Biopharma and Stada consider options for ranibizumab | FW |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 2018-08-31 | |
Boris Döbler
DFI | Director of Finance/CFO | - | 2022-12-31 |
Miguel Fernandez
CTO | Chief Tech/Sci/R&D Officer | 61 | 2014-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jens Steegers
BRD | Director/Board Member | 46 | 2014-06-03 |
Eric Cornut
BRD | Director/Board Member | 69 | 2016-08-25 |
Günter von Au
CHM | Chairman | 75 | 2017-09-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -1.95% | - | - | 5.73B | ||
| +0.75% | +1.55% | +6.93% | +83.72% | 44.96B | ||
| -0.20% | -5.34% | +38.85% | +88.89% | 33.53B | ||
| +0.44% | -0.66% | -8.69% | +43.35% | 11.67B | ||
| -0.11% | +1.85% | +12.86% | +117.57% | 11.62B | ||
| +0.59% | +0.78% | +37.07% | +126.43% | 8.97B | ||
| +2.40% | +0.42% | +17.89% | +42.70% | 6.89B | ||
| -1.12% | +0.77% | +40.21% | -17.13% | 6.55B | ||
| +1.37% | -0.31% | +32.92% | +241.77% | 6.32B | ||
| +0.51% | -2.46% | -39.66% | -6.34% | 5.12B | ||
| Average | +0.46% | -0.61% | +15.37% | +80.11% | 14.14B | |
| Weighted average by Cap. | +0.40% | -1.00% | +17.59% | +84.26% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SAZ Stock
Select your edition
All financial news and data tailored to specific country editions
















